OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies
Yuxian Huang, Yinjie Qin, Yingzhi He, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101082-101082
Open Access | Times Cited: 11
Yuxian Huang, Yinjie Qin, Yingzhi He, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101082-101082
Open Access | Times Cited: 11
Showing 11 citing articles:
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Insights into tumor-derived exosome inhibition in cancer therapy
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 1
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access
Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access
CAR-T therapy and allogeneic stem cell transplantation for refractory acute myeloid leukemia: A comparative study
Nasser Ghaly Yousif, Ulrich Nöth, Fadhil G. Al-Amran
Journal of Hematology and Allied Sciences (2025), pp. 1-7
Closed Access
Nasser Ghaly Yousif, Ulrich Nöth, Fadhil G. Al-Amran
Journal of Hematology and Allied Sciences (2025), pp. 1-7
Closed Access
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond
Jing Nie, Lantian Huang, Yan Shen, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101225-101225
Closed Access
Jing Nie, Lantian Huang, Yan Shen, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101225-101225
Closed Access
Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy
Mohsen Sheykhhassan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 33-92
Closed Access | Times Cited: 1
Mohsen Sheykhhassan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 33-92
Closed Access | Times Cited: 1
Design, Synthesis, Anticancer Evaluation and In Silico Studies of Imidazole Pyrazine Compounds
Gong� Chen, Weiwei Li, Liu Y, et al.
Chemistry & Biodiversity (2024)
Open Access
Gong� Chen, Weiwei Li, Liu Y, et al.
Chemistry & Biodiversity (2024)
Open Access
Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies
Daniela Damiani, Mario Tiribelli
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1629-1629
Open Access
Daniela Damiani, Mario Tiribelli
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1629-1629
Open Access
